A5L-16825-45056
3 vaccinations
11 coded responses
16 check-ins
10 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 853 / AZ
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Chills, Diarrhoea, Fatigue, Nausea, Rash — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to workFree text: After the injection I had chills, joint pain, rash, diarrhea, nausea, fatigue,MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Health check-in — day 7, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-28
Survey response — day 14, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — day 21, dose 2MedDRA: Tinnitus, Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tinnitus, vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-11
Survey response — day 28, dose 2MedDRA: Deafness, Pre-existing disease, Tinnitus — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Worsening tinnitus and hearing lossMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — day 35, dose 2MedDRA: Hyperacusis, Medical counselling, Pre-existing disease, Tinnitus — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Worsening tinnitus and hearing issues · Healthcare visit (other): Curbside. Im a provider.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-25
Survey response — day 42, dose 2MedDRA: Deafness, Tinnitus — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Tinnitus and hearing lossMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
-
2021-06-29
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-29
Call successfulParticipant prefers to complete VAERS report online
-
2022-01-10
Dose 3 — Pfizer-BioNTech
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Fatigue, Headache, Lymphadenopathy, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: After Covid vaccine, severe fatigue, supraclavicular lymphadenopathy, some nausea, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Tinnitus — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Supraclavicular lymphadenopathy, continued tinnitusMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-16
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Tinnitus — Feeling: Poor · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Still supraclavicular lymphadenopathy and tinnitus continuesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-17
Survey response — day 7, dose 3MedDRA: Tinnitus — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Continuing tinnitusMedDRA releases: 2024-11 · check-in free text available
- 2022-01-26
- 2022-04-13
-
2023-01-10
Survey response — 12 months, dose 3MedDRA: Cough, Dyspnoea, Fatigue, Medical counselling, Oxygen saturation decreased, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-01-10
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-01-11
- 2023-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2022-01-10 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): After the injection I had chills, joint pain, rash, diarrhea, nausea, fatigue,
Release 3 — day 14, dose 2
Symptoms: Tinnitus
Release 3 — day 21, dose 2
Symptoms: Tinnitus, vertigo
Release 4 — day 28, dose 2
Symptoms: Worsening tinnitus and hearing loss
Release 4 — day 35, dose 2
Symptoms: Worsening tinnitus and hearing issues
Healthcare visit (other): Curbside. Im a provider.
Release 4 — day 42, dose 2
Symptoms: Tinnitus and hearing loss
Release 10 — 12 months, dose 2
Symptoms: After Covid vaccine, severe fatigue, supraclavicular lymphadenopathy, some nausea, headache
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Supraclavicular lymphadenopathy, continued tinnitus
Systemic reaction (other): Still supraclavicular lymphadenopathy and tinnitus continues
Release 10 — day 7, dose 3
Systemic reaction (other): Continuing tinnitus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Deafness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hyperacusis | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Diarrhoea | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Tinnitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release